VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 404 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2016. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $54,809,000 | -65.8% | 539,193 | -40.0% | 3.01% | -60.7% |
| Q3 2015 | $160,364,000 | +21.3% | 899,000 | +51.1% | 7.66% | +68.7% |
| Q2 2015 | $132,179,000 | -29.9% | 595,000 | -37.4% | 4.54% | -35.0% |
| Q1 2015 | $188,689,000 | +41.2% | 950,000 | +1.8% | 6.98% | +31.9% |
| Q4 2014 | $133,593,000 | +82.9% | 933,500 | +67.7% | 5.30% | +77.4% |
| Q3 2014 | $73,024,000 | -12.0% | 556,590 | -15.4% | 2.98% | -7.7% |
| Q2 2014 | $82,955,000 | – | 657,750 | – | 3.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,586,582 | $864,160,000 | 32.02% |
| FARLEY CAPITAL L.P. | 341,518 | $44,807,000 | 30.12% |
| LeVasseur Capital Partners LLC | 190,404 | $24,981,000 | 29.94% |
| Ruane, Cunniff & Goldfarb | 34,494,015 | $4,525,615,000 | 23.97% |
| ValueAct Holdings | 18,923,877 | $2,482,813,000 | 16.64% |
| White River Investment Partners, LLC | 90,099 | $11,820,000 | 16.35% |
| Tesuji Partners | 1,368,040 | $179,487,000 | 15.45% |
| Arrow Capital Management, LLC | 197,500 | $25,912,000 | 15.11% |
| Hound Partners | 3,576,998 | $469,302,000 | 14.87% |
| Brahman Capital Corp. | 4,457,153 | $584,778,000 | 12.82% |